Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.64B |
| 2 |
Mastercard
MA
|
+$2.05B |
| 3 |
UnitedHealth
UNH
|
+$1.27B |
| 4 |
Coca-Cola
KO
|
+$1.09B |
| 5 |
Bank of America
BAC
|
+$1.07B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.57B |
| 3 |
JPMorgan Chase
JPM
|
+$1.39B |
| 4 |
Wells Fargo
WFC
|
+$1.23B |
| 5 |
Microsoft
MSFT
|
+$1.23B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.47% |
| 2 | Healthcare | 18.43% |
| 3 | Financials | 15.98% |
| 4 | Consumer Discretionary | 9.49% |
| 5 | Industrials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATXS
1651
DELISTED
Astria Therapeutics
ATXS
| $815K | ﹤0.01% |
152,611
+4,562
| +3% | +$31.9K |
|
1652
Aura Biosciences
AURA
$826M
| $814K | ﹤0.01% |
138,952
+7,898
| +6% | +$59.8K |
|
1653
iShares MSCI France ETF
EWQ
$345M
| $814K | ﹤0.01% |
+20,446
| New | +$803K |
|
1654
Absci
ABSI
$1.51B
| $811K | ﹤0.01% |
323,119
-29,686
| -8% | -$109K |
|
1655
Trevi Therapeutics
TRVI
$2.64B
| $802K | ﹤0.01% |
+127,452
| New | +$608K |
|
1656
4D Molecular Therapeutics
FDMT
$562M
| $799K | ﹤0.01% |
247,471
+70,192
| +40% | +$331K |
|
1657
Ligand Pharmaceuticals
LGND
$6.36B
| $795K | ﹤0.01% |
7,562
-41
| -0.5% | -$4.64K |
|
1658
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $792K | ﹤0.01% |
+18,000
| New | +$1.43M |
|
1659
iShares Russell 1000 Value ETF
IWD
$83.7B
| $790K | ﹤0.01% |
4,200
-54
| -1% | -$10.3K |
|
1660
Brookfield Renewable
BEPC
$6.26B
| $785K | ﹤0.01% |
+28,135
| New | +$771K |
|
|
LENZ
1661
LENZ Therapeutics
LENZ
$168M
| $784K | ﹤0.01% |
30,488
+2,272
| +8% | +$56K |
|
1662
Summit Therapeutics
SMMT
$11.1B
| $781K | ﹤0.01% |
40,492
+373
| +0.9% | +$7.48K |
|
1663
Ternium
TX
$10.6B
| $775K | ﹤0.01% |
24,859
-183,968
| -88% | -$5.57M |
|
1664
Rogers Communications
RCI
$18.6B
| $740K | ﹤0.01% |
27,709
-15,715
| -36% | -$444K |
|
1665
Liberty Global Class A
LBTYA
$3.6B
| $737K | ﹤0.01% |
+64,001
| New | +$744K |
|
|
DVAX
1666
DELISTED
Dynavax Technologies
DVAX
| $736K | ﹤0.01% |
56,716
-3,061
| -5% | -$40.5K |
|
1667
State Street SPDR S&P International Small Cap ETF
GWX
$913M
| $731K | ﹤0.01% |
22,857
-8,611
| -27% | -$276K |
|
|
P
1668
Everpure Inc
P
$29.9B
| $730K | ﹤0.01% |
16,480
-134,329
| -89% | -$8.1M |
|
|
TSVT
1669
DELISTED
2seventy bio
TSVT
| $729K | ﹤0.01% |
147,663
-108,906
| -42% | -$346K |
|
1670
Arcutis Biotherapeutics
ARQT
$3.18B
| $729K | ﹤0.01% |
46,640
-2,627
| -5% | -$37K |
|
1671
Abeona Therapeutics
ABEO
$413M
| $729K | ﹤0.01% |
153,121
+59,832
| +64% | +$325K |
|
1672
Supernus Pharmaceuticals
SUPN
$2.77B
| $728K | ﹤0.01% |
22,224
-1,276
| -5% | -$45.2K |
|
1673
Agios Pharmaceuticals
AGIO
$1.93B
| $717K | ﹤0.01% |
24,462
-1,027
| -4% | -$34.1K |
|
1674
Hormel Foods
HRL
$13.8B
| $705K | ﹤0.01% |
22,781
+1,765
| +8% | +$52.4K |
|
1675
Emergent Biosolutions
EBS
$248M
| $695K | ﹤0.01% |
142,966
+7,624
| +6% | +$63.1K |
|
Similar funds
Wellington Management Group's Q1 2025 Portfolio in Review
As of Q1 2025, Wellington Management Group held 2,081 positions worth $520B, down 4.8% from $546B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Wellington Management Group's Q1 2025 filing shows 144 new, 799 increased, 858 reduced and 148 closed positions. Its largest new stake was Aon: 1,229,382 shares worth $491M. The largest sale was Alphabet (Google) Class A, an estimated $1.82B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Wellington Management Group's largest Q1 2025 buy was Aon: 1,229,382 shares worth $491M.
- Wellington Management Group added most to Broadcom in Q1 2025, an estimated $2.64B increase.
- Wellington Management Group's biggest Q1 2025 reduction was Alphabet (Google) Class A, cutting an estimated $1.82B.
- Wellington Management Group fully exited TFI International in Q1 2025, selling an estimated $291M.
- Wellington Management Group's ten largest holdings make up 23% of its $520B portfolio in Q1 2025.
- Wellington Management Group opened 144 new positions and closed 148 in Q1 2025.
- Wellington Management Group's portfolio value fell 4.8% quarter-over-quarter to $520B.
Based on Wellington Management Group's 13F filing for Q1 2025, filed 13 May 2025.